From: Bench-to-bedside review: Pulmonary–renal syndromes – an update for the intensivist
Clinical entities classified according to the pathogenetic mechanism involved |
---|
Pulmonary–renal syndrome associated with anti-GBM antibodies: Goodpasture's syndrome |
Pulmonary–renal syndrome in ANCA-positive systemic vasculitis |
Wegener's granulomatosis |
Microscopic polyangiitis |
Churg–Strauss syndrome |
Other vasculitis |
Pulmonary–renal syndrome in ANCA-negative systemic vasculitis |
Henoch–Schönlein purpura |
Mixed cryoglobulinaemia |
Behçet's disease |
IgA nephropathy |
ANCA-positive Pulmonary–renal syndrome without systemic vasculitis: idiopathic Pulmonary–renal syndrome |
Pauci-immune necrotic glomerulonephritis and pulmonary capillaritis |
Pulmonary–renal syndrome in drug-associated ANCA-positive vasculitis |
Propylthiouracil |
D-Penicillamine |
Hydralazine |
Allopurinol |
Sulfasalazine |
Pulmonary–renal syndrome in anti-GBM-postive and ANCA-positive patients |
Pulmonary–renal syndrome in autoimmune rheumatic diseases (immune complexes and/or ANCA mediated) |
Systemic lupus erythematosus |
Scleroderma (ANCA?) |
Polymyositis |
Rheumatoid arthritis |
Mixed collagen vascular disease |
Pulmonary–renal syndrome in thrombotic microangiopathy |
Antiphospholipid syndrome |
Thrombotic thrombocytopenic purpura |
Infections |
Neoplasms |
Diffuse alveolar haemorrhage complicating idiopathic pauci-immune glomerulonephritis |